U.S. Markets close in 4 hrs 59 mins

Zafgen, Inc. (ZFGN)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.05-0.02 (-0.49%)
As of 11:01AM EDT. Market open.
People also watch
TTPHPTCTOCULCMRXRGLS
Interactive chart
Previous Close4.07
Open4.08
Bid4.03 x 400
Ask4.05 x 400
Day's Range4.02 - 4.09
52 Week Range2.89 - 7.73
Volume23,817
Avg. Volume205,382
Market Cap110.86M
BetaN/A
PE Ratio (TTM)-2.08
EPS (TTM)-1.95
Earnings DateAug 2, 2017 - Aug 7, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est7.00
Trade prices are not sourced from all markets
  • Associated Press14 days ago

    Zafgen reports 1Q loss

    The Boston-based company said it had a loss of 48 cents per share. The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for ...

  • GlobeNewswire14 days ago

    Zafgen Reports First Quarter 2017 Financial Results

    -ZGN-1061 Phase 1 Data Support Continued Development; On Track to Initiate Phase 2 Clinical Trial in Patients with Type 2 Diabetes in Second Half of This Year-. BOSTON, May 09, 2017-- Zafgen, Inc., today ...

  • TheStreet.com19 days ago

    Zafgen Rebounds With a Safer Obesity Drug Targeting Diabetics

    Zafgen is disclosing Thursday evening the first human data on ZGN-1061, with plans to move the obesity drug into a phase II study.